Search

Your search keyword '"Califano, R."' showing total 1 results
Start Over Author "Califano, R." Region united states

Refine your results

1 results on '"Califano, R."'

1. Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration.

Author

Mountzios G, Remon J, Novello S, Blais N, Califano R, Cufer T, Dingemans AM, Liu SV, Peled N, Pennell NA, Reck M, Rolfo C, Tan D, Vansteenkiste J, West H, and Besse B

Subjects
Antibodies, Monoclonal, Humanized pharmacology, B7-H1 Antigen antagonists & inhibitors, B7-H1 Antigen immunology, Carcinoma, Non-Small-Cell Lung immunology, Carcinoma, Non-Small-Cell Lung mortality, Carcinoma, Non-Small-Cell Lung pathology, Disease-Free Survival, Drug Approval, Humans, Lung Neoplasms immunology, Lung Neoplasms mortality, Lung Neoplasms pathology, Progression-Free Survival, Randomized Controlled Trials as Topic, Standard of Care, United States, United States Food and Drug Administration standards, Antibodies, Monoclonal, Humanized therapeutic use, B7-H1 Antigen metabolism, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms drug therapy
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results